K.SehgalA.WeljieA
Our team will help you determine if youre a good candidate for treatment
others take 2-3 weeks Mild injection site reactions (if applicable) are common and self-limited Phase 3: Active Healing Phase (Weeks 3-8) Progressive improvement in symptoms For musculoskeletal conditions, this is the optimal window for physical therapy and rehabilitation For GI conditions, patients often begin reintroducing previously problematic foods Phase 4: Consolidation (Weeks 9-12+) Continued structural healing Transition to maintenance dosing if appropriate Decision point for stacking with TB-500 if additional systemic support is needed Phase 5: Transition and Maintenance Tapering off peptides after goal achievement Maintenance protocols for chronic conditions (e.g., 3 months on, 1 month off) Coordination with long-term wellness strategies (nutrition, exercise, stress management) For more information on conditions that may benefit from this approach, visit my Conditions Treated page
preferably cold Months under refrigeration
Consistent with studies in humans, different studies on Shank mutation sites in mice have also confirmed the strong genetic associations between Shank genes and ASD, especially Shank3
By preserving NAD+ and SAM in both fat and muscle tissue, NNMT inhibition may theoretically address the metabolic dysfunction underlying both excessive fat storage and impaired muscle maintenance
